Nanofactories for Controlled Synthesis and Delivery of Nucleoside Analogue Therapeutics
1Chemistry Research Laboratory, Department of Chemistry, University of Oxford, South Parks Road, OX1 3QR, Oxford.
Abstract:
The ultimate nanomedicine will be a cell-like machinery capable of reaching a specific target in the body and performing a desired therapeutic action in a controlled fashion. To make such machinery a reality, we need to combine fundamental knowledge and technological developments in different areas including polymer chemistry, biology, enzymology, and biochemical engineering. In this viewpoint, I put forward my vision of creating a nanofactory as a step towards developing cell-like nanomedicines. To make the proposed nanofactory a reality there are many challenges ahead. I propose plausible solutions to address some of the main challenges.
Related Concept Videos
01:28Biosynthesis of Nucleic Acids
01:28ATP and Macromolecule Synthesis
Most macromolecules are composed of single subunits, or building blocks, called monomers. The monomers combine with each other using covalent bonds to form larger molecules known as polymers.
Conversion of...